Your search returned 4 results.

Results
	1.	DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment. [electronic resource] by Solier, S Zhang, Y-W Ballestrero, A Pommier, Y Zoppoli, G Producer: 20120808 In: Current cancer drug targets vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. [electronic resource] by Bagnasco, L Piras, D Parodi, S Bauer, I Zoppoli, G Patrone, F Ballestrero, A Producer: 20120808 In: Current cancer drug targets vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. [electronic resource] by Ballestrero, A Garuti, A Cirmena, G Rocco, I Palermo, C Nencioni, A Scabini, S Zoppoli, G Parodi, S Patrone, F Producer: 20120808 In: Current cancer drug targets vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute. [electronic resource] by Zoppoli, G Solier, S Reinhold, W C Liu, H Connelly, J W Monks, A Shoemaker, R H Abaan, O D Davis, S R Meltzer, P S Doroshow, J H Pommier, Y Producer: 20120320 In: Oncogene vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)